Delivery Order SPE2DB20D2104-SPE2DB23FU69V

Award Date 8/3/23
Potential Completion Date 8/4/23
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,850.36 firm fixed-price contract is for the delivery of ABILIFY MAINTENA ER 400 MG SYRS, a specialty pharmaceutical product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,614.02, is for the supply of ABILIFY MAINTENA ER 300 MG SYRS, a mental health treatment medication. The contract has an ultimate completion date of April 9, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,635.14 firm fixed-price contract is for the delivery of Abilify Maintena ER 300 mg syringes. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,211.17 firm fixed price delivery order is for the supply of ABILIFY MAINTENA ER 300 MG VLS, a mental health treatment medication. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,412.67, is for the delivery of ABILIFY MAINTENA ER 300 MG SYRS, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, with ID SPE2DB22D6029|SPE2DB25FLUJE, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,843.01 firm fixed-price delivery order is for the pharmaceutical product ABILIFY MAINTENA ER 400 MG VLS. The contract has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,735.67, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the provision of ABILIFY MAINTENA ER 300 MG VLS, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The award is for the supply of Abilify Maintena ER 400 mg vials, a specialty brand name medication, with a potential value of $5,016.99 and a completion date of February 2, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,522.46 firm fixed-price delivery order is for the supply of 4567447739 ! ABILIFY ER 400MG SY 1S, a pharmaceutical product. The contract has an ultimate completion date of March 5, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $10,608.25 firm-fixed-price delivery order is for the supply of ABILIFY MAINTENA ER 400 MG VLS medication. The delivery order has an ultimate completion date of August 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FU69V
    Delivery Order

This firm fixed-price delivery order contract, valued at $1,625.71, was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ABILIFY MAINTENA ER 400 MG VLS, a mental health medication. This order is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award did not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:16 AM